Fabrice Garrido

Title: Innovations of Fabrice Garrido

Introduction

Fabrice Garrido is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neuropsychological disorders. With a total of 4 patents, his work has garnered attention for its potential therapeutic applications.

Latest Patents

Garrido's latest patents include innovative compounds such as 3,4-dihydro-2-naphthamide derivatives, which serve as selective dopamine D3 ligands. This invention relates to pharmaceutical compositions containing these derivatives and their therapeutic applications as partial agonists or antagonists of the dopamine D3 receptor. These compounds are particularly relevant for the treatment of neuropsychological disorders. Another significant patent involves 2-naphthamide derivatives, which can exist in the form of bases or salts. This invention corresponds to a specific general formula and highlights the versatility of these compounds in therapeutic applications.

Career Highlights

Throughout his career, Fabrice Garrido has worked with esteemed organizations such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and Brioprojet. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Garrido has collaborated with notable colleagues, including Pierre Sokoloff and Camille-Georges Wermuth. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Fabrice Garrido's innovative work in the field of pharmaceuticals demonstrates his commitment to addressing neuropsychological disorders through targeted compounds. His contributions, marked by a total of 4 patents, reflect the importance of collaboration and research in advancing medical science.